|
![]() |
|||
|
||||
OverviewThis book reviews the brilliant progress made in the past three decades in clinical outcomes for osteosarcoma patients treated with a multidisciplinary approach, including limb-salvage surgery combined with neoadjuvant multidrug chemotherapy and aggressive management of pulmonary metastasis. Osteosarcoma was a miserable disease for adolescents and young adults until the early 1970s, with a survival rate that was less than 10–15% even after amputation for affected limbs because of the progression of pulmonary metastasis. With the development of neoadjuvant chemotherapy for osteosarcoma, including high-dose methotrexate, doxorubicin, cisplatin, and ifosfamide during the late 1970s and the 1980s, however, the prognosis has dramatically improved. Limb-salvage surgery for patients with extremity osteosarcoma is now a gold-standard surgical procedure for more than 90% of patients with localized disease. Additionally, aggressive pulmonary metastasectomy for patients with lung metastasis fromosteosarcoma has contributed to improvement of their survival. More recently, carbon-ion radiotherapy has also been introduced for patients with unresectable osteosarcoma of the trunk, as in the spine and pelvis. In this volume the author provides valuable descriptions of an important new treatment modality for a multidisciplinary approach for osteosarcoma patients. Full Product DetailsAuthor: Takafumi Ueda , Akira KawaiPublisher: Springer Verlag, Japan Imprint: Springer Verlag, Japan Edition: Softcover reprint of the original 1st ed. 2016 Weight: 0.591kg ISBN: 9784431566779ISBN 10: 4431566775 Pages: 270 Publication Date: 07 April 2018 Audience: Professional and scholarly , Professional & Vocational Format: Paperback Publisher's Status: Active Availability: Manufactured on demand ![]() We will order this item for you from a manufactured on demand supplier. Table of ContentsPart I: Basic Research and Experimental Therapy.- Chapter 1 Genetics of Osteosarcoma.-Chapter 2 Basic Research for Osteosarcoma Lung Metastasis (LM8).-Chapter 3 Immunotherapy for Osteosarcoma.- Part II: Clinical Features.-Chapter 4 Outcome of Treatment for Osteosarcoma of the Extremities over the Last 20 Years: Report from 11 Referral Centers in Japan.-Chapter 5 Osteosarcoma in the Elderly: Clinical Features and Outcome.-Chapter 6 Prognostic Factors for Osteosarcoma Patients.- Part III: Chemotherapy.-Chapter 7 Neoadjuvant Chemotherapy Developed in Japan.-Chapter 8 Neoadjuvant Chemotherapy (OOS-A, B, C, D regimens).-Chapter 9 Caffeine-Potentiated Chemotherapy for Osteosarcoma.- Part IV: Surgery.-Chapter 10 Endoprosthetic Reconstruction for Extremity Osteosarcoma.-Chapter 11 Limb-Salvage Surgery and Reconstruction for Skeletally Immatur Childhood Osteosarcoma: Extendible Endoprostheses.-Chapter 12 Limb-Salvage Surgery for Pelvic OsteosarcomaChapter 13 Management of Postoperative Infection after Limb Salvage Surgery in Osteosarcoma Patients.- Part V: Surgery : Biological Reconstruction.-Chapter 14 Biological Reconstruction for Extremity Osteosarcoma: Long Term Results and Current Concept of Intraoperative Extracorporeal Irradiated Bone Graft (IORBG).-Chapter 15 Biological Reconstruction for Extremity Osteosarcoma: Pasteurized Autogenous Bone Graft.-Chapter 16 Biological Reconstruction for Extremity Osteosarcoma: Liquid Nitrogen Treated Tumor-Bearing Bone Graft.-Chapter 17 Biological Reconstruction for Extremity Osteosarcoma: Distraction Osteogenesis Technique.-Chapter 18 Limb-Saving Surgery Using In Situ Preparation (ISP) Method.- Part VI: Unresectable / Metastatic Disease.-ReviewsThis book describes the multidisciplinary treatment of osteosarcoma as practiced in Japan. ... This will most likely be of value to trainees in oncology -- medical, radiation, and surgical -- as well as practitioners in the field. ... This is a worthwhile contribution. It is a niche monograph that will be of interest to those in the field who want an update on the techniques and approaches used in Japan. (Carol Scott-Conner, Doody's Book Reviews, June, 2016) Author InformationTakafumi Ueda, Osaka National Hospital, Orthopaedic Oncology Group, Department of Orthopaedic Surgery Akira Kawai, National Cancer Center Hospital, Division of Musculoskeletal Oncology Tab Content 6Author Website:Countries AvailableAll regions |